BALLYMENA, UK, June 26, 2017 CIGA Healthcare ("CIGA"), developer, manufacturer and supplier of professional tests for retail stores, a network of pharmacies and healthcare customers, today announced the signing of a framework agreement on cooperation ("Agreement") with BIOPROMIN LTD , a company specializing in the development of medical non-invasive diagnostic systems. In accordance with the Agreement concluded between CIGA and BIOPROMIN LTD on June 26, 2017, the parties agreed to establish a joint venture to develop, manufacture and sell their own screening, non-invasive diagnostic systems in the UK. The formation of joint production is in the interests of both parties signing a final agreement, which is approved by the governing bodies of the companies and provides for generally accepted conditions for termination. "We are very pleased to be able to join forces with BIOPROMIN LTD. Component production consolidates strong relationships in the pharmaceutical industry CIGA and the long experience of BIOPROMIN LTD in the production and marketing of innovative technologies.The joint production gives us a unique opportunity to use the huge potential of the medical equipment market in Great Britain. we are looking forward to the moment when we can start deliveries of clinically tested instruments to the British market through a joint venture, " said Irwin Armstrong, Chairman and Chief Executive Officer of CIGA.